“PRAC investigating cases of thromboembolic events”: un articolo su Astrazeneca sul sito dell’EMA

Reading Time: < 1 minute

 98 total views,  1 views today

La preziosissima Menita Manzi, mi segnala oggi questo articolo in inglese su Astrazeneca pubblicato sul sito ema.europa.eu:

https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits

Non posso riprodurlo integralmente, per questioni di copyright. Riporto solo il seguente paragrafo a fini di discussione:

There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. The position of EMA’s safety committee PRAC is that the vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing. PRAC is already reviewing all cases of thromboembolic events, and other conditions related to blood clots, reported post-vaccination with COVID-19 Vaccine AstraZeneca.

Come vedete c’è molta, molta cautela da parte dell’EMA, sul nesso di causa-effetto tra la somministrazione e gli eventi trombotici. Ma per fortuna in Italia la Magistratura continua a indagare.